Bhagiradha Chemicals & Industries DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.76×0.86×0.55×0.68×0.71×
0.68×0.58×1.09×0.84×0.94×
8.8%6.8%5.2%7.8%13.4%
0.52×0.52×0.58×0.80×1.27×
1.60×1.60×1.37×1.39×1.43×
3.8%2.8%2.5%5.0%16.3%
2.6%2.6%2.5%5.0%18.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

BHAGCHEM₹194.00

Bhagiradha Chemicals & Industries Limited

· Chemicals
₹ CrorePeersNACLINDDHANUKAGSPCROPBHARATRASINSECTICIDIPLMOLPUNJABCHEMMcap ₹2,516 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.710.680.550.860.76
Interest Burden (Pretax/EBIT) ×0.940.841.090.580.68
EBIT Margin %13.457.835.246.768.77
Asset Turnover ×1.270.800.580.520.52
Financial Leverage (Assets/Equity) ×1.431.391.371.601.60
ROE (5-step product, year-end total equity) %16.294.982.502.833.78
ROE (owners' profit / average owners' equity) %17.955.012.532.632.63
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.